Olanzapine was FDA approved on September 30, 1996, under the brand name Zyprexa. Generic olanzapine is available. Olanzapine side effects Olanzapine may cause serious side effects such as an increased risk of death or stroke in elderly patients with dementia, a higher risk of suicide when taken ...
However, elderly patients are more likely to have dementia or age-related liver, kidney, or heart problems, which may require caution or an adjustment in the dose for patients receiving olanzapine injection. Breast FeedingThere are no adequate studies in women for determining infant risk when ...
This drug is not approved for the treatment of patients with dementia-related psychosis. When using olanzapine and fluoxetine in combination, refer to the Boxed Warning for this combination drug.Safety and efficacy of the extended-release injection have not been established in patients younger than ...
Olanzapine is not approved for the treatment of patients with dementia-related psychosis. (See Increased Mortality in Geriatric Patients with Dementia-related Psychosis in Boxed Warning, see Cerebrovascular Events in Geriatric Patients with Dementia-related Psychosis under Cautions, and also see Dysphagia ...
Psychosis Related to Dementia. There is a higher risk of death, stroke, or mini-stroke in older adults who take olanzapine/fluoxetine or another antipsychotic and have memory loss or psychosis related to dementia. Olanzapine/fluoxetine is not approved to treat dementia-related psychosis. Pregnancy....
Fluoxetine and olanzapine may increase the risk of death in older adults with dementia-related psychosis and is not approved for this use.Tell your doctor if you have ever had:Alzheimer's disease: liver disease; narrow-angle glaucoma; heart problems; high or low blood pressure; low ...
Olanzapine is not approved by the FDA for use in the treatment of behavioral disorders in elderly patients with dementia.[Ref] Metabolic Oral formulations: Very common (10% or more): Weight gain/increased weight greater than/equal to 7% of baseline body weight (up to 89.4%), fasting ...
clinical trials as of October 31, 2011; and (6) 722patients who participated in intramuscular olanzapine for injection premarketing trials in agitated patients with schizophrenia, bipolar I disorder (manic ormixed episodes), ordementia. Also included below is information from the premarketing 6-week ...
摘要: Study Objectives. To compare the effects of risperidone and olanzapine on cognition in elderly patients with dementia and psychosis, and to compare the side effects of these drugs.Design. Single-blind, multicenter, observational study.
Elderly Patients With Dementia-Related Psychosis Increased Mortality Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. ZYPREXA RELPREVV is not approved for the treatment of patients with dementia-related psychosis[see BOXED WARNING, Use In...